The expression and significance of RKIP in Lung squamous cell carcinoma tissues

Chinese Journal of Lung Cancer

Volumn 14, Issue 3, 2011, Pages 194-198

  Xu, Haiyuan ^a   Wang, Xin ^b   Shen, Wenxiang ^a   Wang, Liqiang ^a   Shen, Gang ^a   Chen, Minbin ^a   Zhou, Lina ^a  

^a JIANGSU UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Lung neoplasms; Metastasis; Raf kinase inhibitor protein

Indexed keywords

MESSENGER RNA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ARTICLE; CANCER INVASION; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

EID: 79953227415     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.03.03     Document Type: Article

References (13)

1. Odabaei G, Chatterjee D, Jazirehi AR, et al. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res, 2004, 91: 169-200.
2. Beshir AB, Ren G, Magpusao AN, et al. Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett, 2010, 299(2): 137-149.
3. Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets, 2008, 12(10): 1275-1287.
4. Fu Z, Smith PC, Zhang L, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst, 2003, 95(12): 878-889.
5. Xu YF, Yi Y, Qiu SJ, et al. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J Hepatol, 2010, 53(5): 872-879.
6. Lin K, Baritaki S, Militello L, et al. The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-kappaB/Snail/RKIP/ PTEN circuit. Genes Cancer, 2010, 1(5): 409-420.
7. Al-Mulla F, Hagan S, Al-Ali W, et al. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol, 2008, 61(4): 524-529.
8. Li HZ, Gao Y, Zhao XL, et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res, 2009, 7(6): 832-840.
9. Giangreco A, Groot KR, Janes SM. Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med, 2007, 175(6): 547-553.
10. Lee HC, Tian B, Sedivy JM, et al. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology, 2006, 131(4): 1208-1217.
11. Akaishi J, Onda M, Asaka S, et al. Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer. Anticancer Res, 2006, 26(6B): 4437-4442.
12. Hagan S, Al-Mulla F, Mallon E, et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res, 2005, 11(20): 7392-7397.
13. Yeung K, Janosch P, McFerran B, et al. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol, 2000, 20(9): 3079-3085.